Neurolief’s DP system gets FDA breakthrough device status for depression treatment
Relivion DP is a non-invasive multi-channel brain neuromodulation technology for the treatment of major depression
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Aug 20
Relivion DP is a non-invasive multi-channel brain neuromodulation technology for the treatment of major depression
06 Aug 20
The Portable Neuromodulation Stimulator (PoNS) is authorised for sale in Canada as a class II, non-implantable, medical device…
In a letter, DHSC chief commercial officer Steve Oldfield said the medical supplies industry 'must plan for all…
05 Aug 20
Performing a CT head examination at the patient’s bedside can eliminate costly transports to the radiology department, which…
05 Aug 20
Siemens’ SARS-CoV-2 IgG antibody test provides both a positive or negative result for IgG antibodies
05 Aug 20
The cobas EBV is said to be the first quantitative in vitro diagnostic test for Epstein-Barr virus DNA…
05 Aug 20
ALTO offers a highly differentiated endovascular treatment option to AAA patients and includes design features that we believe…
05 Aug 20
PLATEAU-A Ti Anterior Lumbar Spacer System is a comprehensive system that can be used for anterior fusion procedures
05 Aug 20
The Sublime Radial Access 0.014 RX PTA Catheter allows below-the-knee access through a transradial approach by providing the…
04 Aug 20
The InterStim Micro will help deliver sacral neuromodulation therapy to treat overactive bladder, fecal incontinence and non-obstructive urinary…